Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: G7 warns of Brexit risks

Fri, 27th May 2016 07:29

(ShareCast News) - Stocks are set for a slightly lower open as traders tread cautiously ahead of a speech by Fed chair Janet Yellen towards the close of trading in London and ahead of the release of key economic indicators Stateside.The fact that investors are heading into a long weekend on both sides of the Pond, ahead of key risk events next week including the US jobs report for May and an OPEC summit is also expected to restrain activity today.With little doubt, all eyes are on Yellen´s speech at Harvard University, which is scheduled for 15:30BST; although the possibility exists that she will not make policy relevant remarks, even the risk that she might is enough to keep many traders on the sidelines.The Footsie is seen starting the day 3 points higher from Thursday closing mark of 6,265.65."At the moment, it is all about Miss Yellen and all focus will be on her as she takes to the stage later today. Many think that she will be very hawkish and possibly reverberate the same message as her fellow colleagues; that the US economy warrants another rate hike," said Naeem Aslam, chief market analyst at Think Forex UK."We don't think it's the right venue," said Michael Gapen, chief US economist at Barclays Investment Bank. "I would be surprised if she made comments."Any comments would come after a hawkish set of FOMC minutes last week and several Fed governors adding since then that two to three rate hikes were on the table in 2016, possibly including at the next meeting, on 14-15 June.Acting as a backdrop, following their meeting at Ise-Shima, in central Japan, G7 leaders warned of the damage that Brexit might inflict."A UK exit from the EU would reverse the trend towards greater global trade and investment, and the jobs they create, and is a further serious risk to growth," they said in an official statement.The main Asian stock gauges are broadly higher, with the Shanghai Stock Exchange´s Composite Index standing 0.22% higher at 2,828.57 as of 07:30 BST.To take note of, reports indicate that Japanese prime minister Shinzo Abe might announce a decision to postpone a planned increase in the country´s consumption tax in April 2017.Linked to the above, figures released overnight revealed that core consumer prices in the Tokyo area - a lead indicator for price pressures in the world´s third-largest economy - slipped to a -0.5% year-on-year clip in May (consensus: -0.4%).On the data front, the main releases on Friday will be a second reading on US first quarter GDP at 13:30 BST followed ninety minutes later by the University of Michigan´s consumer confidence survey results for the end of May.Finance post up for grabs at WolseleyWolseley said on Friday that Simon Nicholls will not take up his role as chief financial officer later this year, as announced back in January, without giving any reasons. The FTSE 100 building materials group said David Keltner, current CFO of US subsidiary Ferguson Enterprises, will be appointed interim group CFO on 1 September and the selection process to appoint a permanent CFO will commence immediately. The company confirmed Ian Meakins will retire on 31 August 2016, while John Martin will succeed him as CEO on the 1 September as expected.Phamaceuticals giant AstraZeneca announced positive results for its Faslodex drug for the treatment of metastatic breast cancer in post-menopausal women who have not had prior hormonal treatment for home-receptor-positive breast cancer. The company said on Friday that Faslodex met its primary endpoint of extended progression-free survival.In addition, AZN said the US Food & Drug Administration has issued a complete response letter on the new drug application made for sodium zirconium cyclosilicate, the investigational medicine being developed for the treatment of hyperkalaemia (high potassium level in the blood serum) by wholly-owned subsidiary ZS Pharma.
More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.